ARCH Venture Fund VIII, L.P. SEC EDGAR Filings (CIK 0001605598)

SEC EDGAR filings, ownership reports, and insider transactions for ARCH Venture Fund VIII, L.P..

Business address
8755 W. Higgins Road, Suite 1025, Chicago, IL, 60631
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
ARCH Venture Fund VIII, L.P. has filed 38 SEC EDGAR filings since 24 Apr 2014

Latest Filings

Recent SEC filings for ARCH Venture Fund VIII, L.P. including SC 13G/A, SC 13D, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCH 13G/A(#2E) 13 May 2024
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORP -- SCH 13G/A(#2E) 14 Feb 2024
SC 13D Open SC 13D document View SEC filing for SC 13D ARCH VENTURE FUND VIII, L.P. -- CODIAK BIOSCIENCES, INC. -- SCHEDULE 13D 20 Sep 2022
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 15 Sep 2022 13 Sep 2022 001-39615
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#3E) 08 Feb 2022
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND VIII, L.P. - CODIAK BIOSCIENCES, INC. -- SCH 13G 04 Feb 2021
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND VIII, L.P. - METACRINE, INC. -- SCH 13G 02 Feb 2021
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#2) 02 Feb 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Oct 2020 16 Oct 2020 001-39615
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 13 Oct 2020 13 Oct 2020 001-39615
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Sep 2020 18 Sep 2020 001-39512
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 15 Sep 2020 15 Sep 2020 001-39512
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORPORATION -- SCHEDULE 13G/ 13 Feb 2020
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCHEDULE 13G/A(#1) 13 Feb 2020
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G/A(#1) 13 Feb 2020
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 12 Aug 2019 08 Aug 2019 001-38311
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 23 May 2019 21 May 2019 001-38433
SC 13D Open SC 13D document View SEC filing for SC 13D ARCH VENTURE FUND VIII, L.P. - SIENNA BIOPHARMACEUTICALS -- SCHEDULE 13D 06 Mar 2019
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 26 Feb 2019 22 Feb 2019 001-38155
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - SIENNA BIOPHARMACEUTICALS, INC. -- SCHEDULE 13G/A 14 Feb 2019
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND VIII, L.P. - SCHOLAR ROCK HOLDING CORP -- SCHEDULE 13G 14 Feb 2019
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND VIII, L.P. - KURA ONCOLOGY, INC. -- SCHEDULE 13G/A(#3) 14 Feb 2019
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G 14 Feb 2019
4 Open 4 document View SEC filing for 4 4 31 May 2018 29 May 2018 001-38501
3 Open 3 document View SEC filing for 3 3 23 May 2018 23 May 2018 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 04 Apr 2018 02 Apr 2018 001-38433
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Mar 2018 27 Mar 2018 001-38433
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VIII - SIENNA BIOPHARMACEUTICALS, INC. 13G 02 Feb 2018
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VIII - DENALI THERAPEUTICS INC. 13G 02 Feb 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Dec 2017 12 Dec 2017 001-38311
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 Dec 2017 07 Dec 2017 001-38311
4 Open 4 document View SEC filing for 4 FORM 4 01 Aug 2017 01 Aug 2017 001-38155
3 Open 3 document View SEC filing for 3 FORM 3 26 Jul 2017 26 Jul 2017 001-38155
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A KURA ONCOLOGY, INC. -- SCHEDULE 13G (AMEND. #2) 13 Feb 2017
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A KURA ONCOLOGY - AMEND. #1 16 Feb 2016
SC 13G Open SC 13G document View SEC filing for SC 13G KURA ONCOLOGY 13 Mar 2015
D/A Open D/A document View SEC filing for D/A 27 Aug 2014 021-216149
D Open D document View SEC filing for D 24 Apr 2014 021-216149

About this filer

ARCH Venture Fund VIII, L.P. files with the SEC under CIK 0001605598. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages